GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 280 filers reported holding GW PHARMACEUTICALS PLC in Q4 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $26,875,000 | +273.3% | 123,907 | +98.6% | 0.01% | +300.0% |
| Q4 2020 | $7,199,000 | +21.4% | 62,379 | +2.4% | 0.00% | 0.0% |
| Q3 2020 | $5,928,000 | +7.4% | 60,889 | +35.3% | 0.00% | 0.0% |
| Q2 2020 | $5,521,000 | +45.9% | 44,988 | +4.1% | 0.00% | 0.0% |
| Q1 2020 | $3,784,000 | -84.1% | 43,213 | -81.0% | 0.00% | -78.6% |
| Q4 2019 | $23,840,000 | -5.8% | 228,001 | +3.6% | 0.01% | -12.5% |
| Q3 2019 | $25,314,000 | -52.1% | 220,062 | -28.2% | 0.02% | -51.5% |
| Q2 2019 | $52,869,000 | -2.5% | 306,685 | -4.7% | 0.03% | -5.7% |
| Q1 2019 | $54,219,000 | +57.5% | 321,643 | -9.0% | 0.04% | +34.6% |
| Q4 2018 | $34,420,000 | -42.2% | 353,427 | +2.6% | 0.03% | -33.3% |
| Q3 2018 | $59,522,000 | +37.3% | 344,577 | +11.0% | 0.04% | +30.0% |
| Q2 2018 | $43,337,000 | +24.6% | 310,567 | +0.6% | 0.03% | +20.0% |
| Q1 2018 | $34,786,000 | -20.7% | 308,743 | -7.1% | 0.02% | -19.4% |
| Q4 2017 | $43,863,000 | +53.5% | 332,273 | +18.0% | 0.03% | +47.6% |
| Q3 2017 | $28,569,000 | -10.4% | 281,493 | -11.5% | 0.02% | -16.0% |
| Q2 2017 | $31,875,000 | -8.0% | 317,956 | +11.0% | 0.02% | -10.7% |
| Q1 2017 | $34,646,000 | +13.2% | 286,475 | +4.6% | 0.03% | +7.7% |
| Q4 2016 | $30,615,000 | -9.0% | 273,956 | +8.1% | 0.03% | -7.1% |
| Q3 2016 | $33,629,000 | +12.8% | 253,367 | -22.2% | 0.03% | +7.7% |
| Q2 2016 | $29,804,000 | +15.8% | 325,477 | -8.8% | 0.03% | +18.2% |
| Q1 2016 | $25,746,000 | -10.7% | 356,834 | -14.1% | 0.02% | -12.0% |
| Q4 2015 | $28,835,000 | -8.8% | 415,254 | +20.0% | 0.02% | -7.4% |
| Q3 2015 | $31,625,000 | -38.5% | 346,121 | -17.4% | 0.03% | -37.2% |
| Q2 2015 | $51,453,000 | +24.6% | 418,864 | -7.6% | 0.04% | +30.3% |
| Q1 2015 | $41,307,000 | +20.4% | 453,280 | -10.5% | 0.03% | +17.9% |
| Q4 2014 | $34,295,000 | -10.0% | 506,725 | +7.6% | 0.03% | -12.5% |
| Q3 2014 | $38,091,000 | -4.9% | 471,134 | +26.2% | 0.03% | -5.9% |
| Q2 2014 | $40,066,000 | +139.4% | 373,440 | +32.5% | 0.03% | +142.9% |
| Q1 2014 | $16,733,000 | – | 281,840 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|